2023 annual financial data
Wave Life Sciences 2023 Operating margin
Wave Life Sciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -60.01%.
Operating income was -67,996,000 USD and net income was -57,513,000 USD.
Operating cash flow was -19,431,000 USD.
Get free Wave Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 113,305,000 USD
- Operating income
- -67,996,000 USD
- Net income
- -57,513,000 USD
- Operating cash flow
- -19,431,000 USD